Back to Articles
49732027 Q1PrimeJGAAP

JAPAN PURE CHEMICAL CO.,LTD. FY2027 Q1 Earnings Report

JAPAN PURE CHEMICAL CO.,LTD. FY2027 Q1 earnings report and financial analysis

Raw Materials & Chemicals/Chemicals


Quick View

MetricCurrent PeriodSame Period Previous YearYoY
Revenue¥6.15B¥3.41B+80.6%
Operating Income¥0.03B¥0.09B−66.3%
Ordinary Income¥0.12B¥0.18B−33.4%
Net Income¥0.09B¥0.14B−34.5%
ROE0.4%0.7%-

Executive Summary

While Revenue surged 80.6% year on year, Operating Income declined 66.3%, resulting in higher revenue but lower profit. Revenue was ¥6.15B, Operating Income was ¥0.03B (¥0.09B in the same period of the previous year), Ordinary Income was ¥0.12B (down 33.4%), and Net Income was ¥0.09B (down 34.5%). Despite the increase in Revenue, the gross margin remained at 6.3%, while SG&A expenses accounted for 92.0% of gross profit, meaning that Revenue growth did not translate into profit growth.

Factors Affecting Earnings

【Revenue】Revenue increased substantially to ¥6.15B (¥3.41B in the same period of the previous year, YoY +80.6%). Progress against the full-year company plan of ¥24.0B was 25.6%, slightly above the standard level for Q1.

【Profit and Loss】Cost of sales expanded to ¥5.76B, leaving the gross margin at 6.3%. SG&A expenses of ¥0.36B accounted for 92.0% of gross profit of ¥0.39B. Operating Income was ¥0.03B (YoY down 66.3%), and the Operating Income margin contracted sharply to 0.5% from approximately 2.7% in the previous year. Ordinary Income of ¥0.12B was supported by non-operating income of ¥0.09B (including dividend income of ¥0.09B), but this was insufficient to offset the decline in Operating Income, resulting in a year-on-year decrease of 33.4%. Net Income was ¥0.09B (down 34.5%). The results showed higher revenue but lower profit, highlighting the issue that Revenue growth has not translated into cost absorption or price pass-through.

Key Financial Indicators

【Profitability】The Operating Income margin of 0.5% contracted by approximately 220bp from approximately 2.7% in the same period of the previous year, while the Net Income margin of 1.4% also declined from approximately 3.9% in the previous year. The gross margin of 6.3% is thin, indicating limited resilience to cost fluctuations. 【Cash Quality】Dividend income of ¥0.09B accounted for 74% of Ordinary Income of ¥0.12B, requiring separate evaluation of operating earnings and investment income. The effective tax rate was 28.1%, and the gap between profit before tax and Net Income was within a reasonable range. 【Investment Efficiency】ROE was 0.4% and ROIC was 0.6%, both at low levels, indicating insufficient earnings generation from the ¥17.96B in investment securities, which accounted for 64.2% of total assets. 【Financial Soundness】The company has an extremely conservative financial structure, with an Equity Ratio of 79.7%, a current ratio of 2,633.4%, and a debt-to-equity ratio of 0.25x. Concerns regarding short-term liquidity and leverage are therefore limited.

Cash Flow Analysis

As the Operating Cash Flow (OCF) statement data was not included in the disclosure, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits amounted to ¥6.62B, down from ¥7.75B in the previous year, while investment securities increased by ¥6.69B year on year to ¥17.96B, suggesting that some cash on hand may have been redirected to securities investments. Accounts receivable increased to ¥2.40B, accounting for 24.7% of current assets, while inventories were ¥0.19B, representing only 0.7% of total assets. Current assets of ¥9.70B provide substantial coverage against current liabilities of ¥0.37B, indicating limited concerns regarding working-capital liquidity. Since Net Income of ¥0.09B includes a contribution of ¥0.09B from dividend income, the cash-generation capacity of the core business is likely lower than the disclosed Net Income level.

Quality of Earnings

Net Income for the current period of ¥0.09B was supported by Operating Income of ¥0.03B and non-operating income of ¥0.09B, primarily consisting of dividend income of ¥0.09B. Non-operating income therefore accounted for 74% of Ordinary Income. Extraordinary items were immaterial, consisting only of extraordinary income of ¥0.00B, and no temporary factors contributed to the increase in current-period profit. The difference between profit before tax of ¥0.12B and Net Income of ¥0.09B was ¥0.03B in corporate income taxes and other taxes (effective tax rate: 28.1%), with no unusual tax burden. However, since Operating Income derived from the core business remained at only ¥0.03B, earnings quality is characterized by a high dependence on investment income. Attention is warranted because the dividend policies of investee companies and fluctuations in the valuation of securities may affect earnings stability going forward.

Earnings Forecast and Guidance

Revenue progress against the full-year company plan was 25.6%, a standard level, while progress for Operating Income was only 5.1% and progress for Net Income was only 4.1%. To achieve the full-year Operating Income plan of ¥0.61B (up 5.8% year on year), the Operating Income margin must rise from the current 0.5% to approximately 2.5%, as assumed in the plan, from Q2 onward. Progress for Ordinary Income was 15.3%, supported by non-operating income centered on dividend income. Achieving the Net Income plan of ¥2.17B (up 20.3% year on year) will require a substantial accumulation of profit exceeding the Q1 result, indicating that progress against the plan is weighted toward the second half.

Shareholder Returns

The company forecasts an annual dividend of ¥230 per share. Based on forecast EPS of ¥373.93, the Payout Ratio is approximately 61.5%, slightly above the general benchmark of 60%. The company holds 258,000 treasury shares, but the acquisition amount for the current period has not been disclosed; therefore, the Total Return Ratio has not been calculated. The financial foundation—net assets of ¥22.32B, cash and deposits of ¥6.62B, and a debt-to-equity ratio of 0.25x—supports dividend stability. However, Q1 progress against the full-year Net Income plan was only 4.1%, making the accumulation of earnings supporting the annual dividend a challenge from Q2 onward.

Risk Factors

  1. Risk of declining profitability: Gross margin and Operating Income margin were thin at 6.3% and 0.5%, respectively, meaning that fluctuations in raw material and selling prices have a significant impact on Operating Income. While Revenue increased 80.6%, Operating Income declined 66.3%, making cost absorption and price pass-through during periods of Revenue growth key challenges.

  2. Risk of dependence on investment securities: Investment securities of ¥17.96B accounted for 64.2% of total assets and 80.5% of net assets, while dividend income accounted for 74% of Ordinary Income. Changes in securities valuations or in the dividend policies of investee companies could directly affect net assets and Ordinary Income.

  3. Risk of failing to achieve the earnings plan: Q1 progress against the full-year Operating Income plan was only 5.1%, and progress for Net Income was only 4.1%, requiring a substantial improvement in profitability from Q2 onward. Although financial soundness is high, as indicated by an Equity Ratio of 79.7% and a current ratio of 2,633.4%, improving the profitability of the core business will be critical to achieving the plan.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Income Margin0.5%8.7% (4.2%–14.3%)−8.2pt
Net Income Margin1.4%7.1% (3.2%–10.6%)−5.7pt

Profitability was substantially below the industry median, with both the Operating Income margin and Net Income margin ranking at low levels.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (Year on Year)80.6%6.2% (-1.1%–14.6%)+74.4pt

The Revenue growth rate was exceptionally high within the industry and ranked at an upper level.

※Source: Compiled by the Company

Key Takeaways from the Results

  1. Revenue increased 80.6% year on year, demonstrating exceptionally strong growth even within the industry. However, the decline in the Operating Income margin to 0.5% indicates that Revenue growth has not translated into profit growth.

  2. Dividend income of ¥0.09B accounted for 74% of Ordinary Income of ¥0.12B. When evaluating the earnings figures, operating profit and investment income should therefore be assessed separately.

  3. The conservative financial structure—an Equity Ratio of 79.7%, a current ratio of 2,633.4%, and a debt-to-equity ratio of 0.25x—together with the asset composition including ¥17.96B in investment securities indicates that securities prices and dividend trends have a greater potential impact on net assets than business risk.

Theoretical Share Price (Reference Value)

ScenarioTheoretical Share Price
bear (bearish)¥3,095
base (base case)¥3,119
bull (bullish)¥3,138
Valuation AssumptionValue
Book Value per Share (BPS)¥3,827
Adjusted Forecast EPS¥106.5
Cost of Equity r9.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 1.00%)
Residual Income Persistence Factor ω / Explicit Forecast Period0.62 / 5 years
Assumed Payout Ratio61.5%
Forecast EPS Confidence Adjustment×1.075 (based on the industry’s historical guidance achievement rate)
Implied PBR / PER0.81x / 29.3x

Sensitivity: ¥3,035–¥3,206 at Cost of Equity ±1%; ¥3,097–¥3,133 at ω ±0.1.

Notes:

  • Normalized EPS calculated from Ordinary Income and other figures is used to exclude the effects of temporary profit and loss items (company forecast EPS is ¥373.9).
  • Since forecast ROE is below the Cost of Equity, the theoretical value is below book value per share.
  • Net assets as of the quarter-end are used (there is a timing difference relative to the full-year forecast).

(Model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest Rate Reference Month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)


This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

FY2027 Q1 performance was operationally weak despite exceptional 80.6% YoY revenue growth. Revenue increased to ¥6.152bn from ¥3.406bn. Gross profit nevertheless declined 4.2% YoY to ¥0.389bn because cost of sales rose 92.1%, faster than sales. The gross margin contracted by 564bp to 6.3% from 11.9%. SG&A expenses increased 14.2% YoY to ¥0.358bn, materially below sales growth but close to the reduced gross-profit pool. Operating income fell 66.3% YoY to only ¥0.031bn. The operating margin compressed by 220bp to 0.5% from 2.7%. Ordinary income declined 33.4% YoY to ¥0.122bn, outperforming operating income because dividend income contributed ¥0.901bn. Net income decreased 34.5% YoY to ¥0.088bn. The net margin declined by 253bp to 1.4% from 4.0%. Thus, reported earnings remain substantially dependent on returns from the securities portfolio rather than manufacturing operations. Investment securities reached ¥17.956bn, equal to 64.2% of total assets, and valuation gains lifted equity materially. The balance sheet is highly liquid, with a 2,633.4% current ratio and ¥6.623bn of cash and deposits. The principal near-term earnings issue is whether the sharp sales expansion can convert into a sustainable recovery in gross margin and operating profit. Full-year guidance implies that earnings are expected to be heavily weighted toward later quarters, particularly at the operating-profit and net-income levels. The unchanged FY2027 dividend forecast of ¥230 per share implies management remains confident in shareholder returns, although the planned dividend is high relative to forecast EPS.

Profitability Analysis

Annualized DuPont ROE was 1.6%, comprising a 1.4% net profit margin, 0.879x asset turnover, and 1.25x financial leverage. The weak net margin is the principal constraint on return on equity, while leverage is conservative and does not artificially amplify shareholder returns. Asset turnover is relatively solid on an annualized basis, but it did not translate into returns because the gross margin fell to 6.3% and the EBIT margin to 0.5%. The largest adverse operational change was gross-margin compression: sales grew 80.6%, whereas cost of sales rose 92.1%, reducing gross profit by ¥0.017bn. SG&A rose only 14.2%, demonstrating expense restraint, but this was insufficient to offset the gross-profit deterioration. The current 0.5% operating margin is materially below the 5% concern threshold and is explicitly consistent with the low-operating-efficiency quality alert. The 6.3% gross margin is also below the 20% reference threshold and reflects limited pricing and/or product-mix resilience during the quarter. Annualized ROIC of 0.6% is below 5%, indicating that operating capital is currently generating a very low return. Non-operating dividend income of ¥0.901bn was 146.4% of operating income and represented 14.6% of quarterly revenue, making ordinary profit substantially portfolio-income driven. The 71.5% tax burden was normal, while the 3.973x interest burden reflects ordinary income materially exceeding EBIT rather than debt-financing benefits. As a JGAAP standalone manufacturer, the absence of material intangible intensity, at 0.4% of assets, means goodwill amortization is not a meaningful explanation for the low reported operating profitability.

Growth Assessment

Revenue growth of 80.6% is strong in absolute terms, but its quality is weakened by the inability to retain sufficient gross profit. Gross profit declined despite the revenue expansion, indicating that the incremental sales carried a substantially lower margin than the prior-year business mix. The ¥0.631bn increase in inventory, or 49.3% YoY, should be monitored alongside sales momentum because inventory growth can reflect either production preparation for demand or less favorable stock turnover. Receivables increased 25.0% YoY to ¥2.396bn, markedly slower than revenue growth, which is directionally supportive of collection discipline. Full-year revenue guidance is ¥24.0bn, implying Q1 progress of 25.6%, broadly in line with the standard 25% first-quarter run rate. In contrast, Q1 operating-income progress is only 5.1% against the ¥0.610bn full-year forecast, 19.9 percentage points below the standard progress rate. Ordinary-income progress is 15.3% against the ¥0.800bn forecast, also below a normal first-quarter pace but supported by dividend income. Net-income progress is only 4.1% against the ¥2.170bn full-year forecast, 20.9 percentage points below the standard pace. The implied back-half recovery requires a major improvement in operating profitability and/or substantial non-operating or valuation-related contributions. Full-year guidance calls for 32.8% revenue growth, 5.8% operating-income growth, 3.1% ordinary-income growth, and 20.3% net-income growth. This outlook suggests that management expects sales growth to normalize after Q1 and margins to recover substantially from the current trough. Sustainability of the growth thesis depends chiefly on gross-margin normalization rather than further top-line expansion alone.

Financial Health

Financial health is strong from a short-term liquidity and balance-sheet leverage perspective. Current assets of ¥9.696bn exceed current liabilities of ¥0.368bn by ¥9.328bn, producing working capital of ¥9.328bn. The current ratio of 2,633.4% and quick ratio of 2,581.2% indicate no near-term liquidity stress. Cash and deposits of ¥6.623bn alone are approximately 18.0 times current liabilities. The reported debt-to-equity ratio is 0.25x, well below the 2.0x warning threshold, and equity represents 79.7% of total assets. No maturity mismatch is evident because current assets substantially exceed current obligations. Noncurrent liabilities of ¥5.302bn are dominated by deferred tax liabilities of ¥5.073bn, which are principally associated with unrealized valuation gains rather than conventional financing debt. Investment securities increased ¥7.212bn, or 67.1% YoY, to ¥17.956bn and now account for 64.2% of assets. This portfolio concentration is the defining balance-sheet consideration: it enhances asset value and dividend-income capacity but exposes equity and deferred-tax balances to market-value movements. Total equity increased ¥4.251bn YoY to ¥22.315bn, supported primarily by the increase in valuation and translation adjustments to ¥11.352bn from ¥6.412bn. Treasury stock was ¥0.615bn, equivalent to 2.2% of assets, while book value per share was ¥3,826.83. Asset retirement obligations were ¥0.048bn, equal to approximately 0.9% of total liabilities, indicating limited disclosed environmental restoration obligations relative to the liability base.

Notable B/S Changes

Investment securities: +¥7.212bn (+67.1%) to ¥17.956bn - securities now represent 64.2% of total assets, increasing portfolio-income capacity but also market-valuation concentration. Inventories: +¥0.636bn (+49.3%) to ¥0.192bn - inventory expanded materially and should be assessed against future sales conversion and margin recovery. Valuation and translation adjustments: +¥4.940bn (+77.0%) to ¥11.352bn - unrealized gains materially strengthened reported equity but increase sensitivity to financial-market movements. Deferred tax liabilities: +¥2.308bn (+83.5%) to ¥5.073bn - largely offsets valuation-reserve growth and reflects the tax exposure associated with unrealized investment gains. Cash and deposits: -¥1.131bn (-14.6%) to ¥6.623bn - liquidity remains ample, but cash declined while investment securities increased substantially.

Cash Flow Quality

Dividend Sustainability

The full-year dividend forecast is ¥230 per share, unchanged from the latest disclosed policy. Based on forecast EPS of ¥373.93, the implied dividend payout ratio is approximately 61.5%. This is slightly above the 60% sustainability reference level, leaving a narrower buffer than a more conservative payout policy. The forecast dividend is supported by a very strong liquidity position, substantial investment securities, and a high equity ratio. However, the Q1 EPS of ¥15.25 is only 4.1% of forecast full-year EPS, emphasizing that the planned dividend depends on a substantial improvement in earnings over the remaining quarters. The dividend-income stream of ¥0.901bn in Q1 provides an additional source of ordinary earnings, though its resilience is linked to portfolio-company distributions. No dividend revision was announced. The key indicators for dividend durability are achievement of the ¥2.170bn net-income forecast, the market value and income generation of investment securities, and preservation of the current net-cash liquidity position.

Risk Assessment

Business risks include Margin and product-mix risk: the 564bp YoY decline in gross margin to 6.3% shows that rapid sales expansion is not currently translating into profitable growth., Chemical-manufacturing input-cost risk: cost of sales increased 92.1% YoY, exceeding 80.6% revenue growth, leaving the business vulnerable to raw-material, energy, and procurement-cost inflation., Inventory risk: inventories rose 49.3% YoY to ¥0.192bn, requiring continued sales conversion to avoid future valuation or obsolescence pressure., Execution risk versus guidance: Q1 operating-income progress of 5.1% and net-income progress of 4.1% are each more than 10 percentage points below the normal 25% first-quarter pace., Environmental and regulatory risk: as a chemical manufacturer, compliance costs, process-safety requirements, and remediation obligations can affect operating costs and plant utilization..

Financial risks include Investment-portfolio concentration: investment securities of ¥17.956bn equal 64.2% of total assets, creating material exposure to equity-market valuation changes., Deferred-tax exposure: deferred tax liabilities of ¥5.073bn represent 89.5% of total liabilities and are linked to accumulated unrealized gains; a portfolio-value decline would reduce both valuation reserves and related deferred-tax liabilities., Earnings dependence on portfolio income: dividend income of ¥0.901bn was nearly three times operating income of ¥0.031bn, reducing the share of earnings generated by core operations., Low capital efficiency: the 0.6% annualized ROIC and 1.6% annualized ROE indicate that the present capital base is not generating adequate operating returns..

Key concerns include HIGH PRIORITY: The low-operating-efficiency alert is substantiated by a 0.5% EBIT margin. The root cause is the disproportionate increase in cost of sales relative to revenue. This materially raises the level of gross-margin recovery required to achieve full-year operating guidance., HIGH PRIORITY: The low-gross-margin alert is substantiated by a 6.3% gross margin, down from 11.9% a year earlier. In a specialty chemical manufacturer, this may reflect unfavorable pricing, input costs, or lower-margin customer and product mix. The impact is a sharp reduction in operating leverage despite strong revenue growth., HIGH PRIORITY: The capital-efficiency alert is substantiated by 0.6% annualized ROIC and 1.6% annualized ROE. The company has conservative financial leverage, so the issue is operating return generation rather than balance-sheet risk. A sustained low return would weaken the rationale for maintaining a very large investment portfolio relative to operating assets., MEDIUM PRIORITY: The FY2027 dividend forecast implies a 61.5% payout ratio on forecast EPS, slightly above the 60% reference level. The payout remains plausible given liquidity, but is more sensitive to a shortfall in full-year earnings., MEDIUM PRIORITY: Mark-to-market gains embedded in the securities portfolio have become increasingly important to equity, with valuation and translation adjustments rising ¥4.940bn YoY..

Investment Implications

Key takeaways include Q1 revenue growth was exceptional at 80.6%, but operating income fell 66.3%, demonstrating that sales growth alone is not currently creating shareholder value., The core operational metric to monitor is gross margin, which declined to 6.3% from 11.9% and drove the EBIT margin down to 0.5%., Ordinary income benefited from ¥0.901bn of dividend income, highlighting the strategic importance of the large investment-securities portfolio., Liquidity and solvency are strong, with ¥9.328bn of working capital, a 2,633.4% current ratio, and a 0.25x debt-to-equity ratio., Investment securities are both a balance-sheet strength and a concentration risk, representing 64.2% of total assets., Achievement of full-year guidance requires earnings to be materially back-end loaded..

Metrics to watch include Quarterly gross margin and operating margin, particularly evidence that cost of sales grows more slowly than revenue, Progress toward full-year operating income of ¥0.610bn and net income of ¥2.170bn, Dividend income from investment securities and the market value of the ¥17.956bn portfolio, Inventory trend relative to sales, following the 49.3% YoY increase, Changes in valuation and translation adjustments and deferred tax liabilities, Dividend payout ratio relative to forecast EPS and earnings delivery.

Regarding relative positioning, The company has an unusually asset-rich and liquid financial profile for a small standalone manufacturer, but its current operating-return profile is weak. Its balance-sheet resilience is stronger than its earnings quality at the operating level: annualized ROE of 1.6%, annualized ROIC of 0.6%, a 6.3% gross margin, and a 0.5% EBIT margin are below standard profitability benchmarks. Relative positioning therefore depends more on the value and income contribution of its securities portfolio than on demonstrated manufacturing operating leverage in Q1.